MDLZ Current Ratio Analysis
Updated 1035h ago·SEC filings & market data
Key Takeaway
The current ratio measures whether a company can cover short-term debts with short-term assets; MDLZ’s 0.54x means it has only $0.54 in current assets for every $1 of current liabilities.
Sector Performance
9th percentileMDLZ
0.54x
Sector Median
1.26x
Sector Avg
2.60x
Deep Analysis
The current ratio measures whether a company can cover short-term debts with short-term assets; MDLZ’s 0.54x means it has only $0.54 in current assets for every $1 of current liabilities.
That is far below the sector median of 1.22x, placing the company at the 8th percentile among peers, so liquidity is weak relative to the group. Trend data is not available: the year-over-year change is N/A and the quarter-over-quarter change is N/A, leaving the historical path unknown. The low level alone suggests higher short-term solvency risk, but with no trend direction, you cannot tell if this is improving or deteriorating. That combination makes the liquidity picture a risk factor, offset by the absence of a worsening signal. This metric contradicts a full bullish case but is consistent with the NEUTRAL verdict, since the low ratio flags caution while the missing trend leaves room for uncertainty.
Frequently Asked Questions
What does the Current Ratio tell investors about MDLZ?
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
How is the Current Ratio calculated?
Current Ratio is calculated as: Current Assets / Current Liabilities.
Learn More About Current Ratio
The Formula
Current Assets / Current Liabilities
Why It Matters
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
Master MDLZ's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MDLZ research report →MDLZ
0.54x
Sector Median
1.26x
Sector Avg
2.60x
How MDLZ's Current Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.